Antibiotic study for hospitalized children with bacterial infections
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a single dose of an investigational antibiotic called gepotidacin in hospitalized children with bacterial infections who already have an IV line. The medicine is given as a powder mixed with food, and the study aims to see how well it is absorbed and tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Children aged 2 to under 12 years old, weighing at least 10 kilograms (about 22 pounds).
- The child must have a bacterial infection (or be taking antibiotics to prevent one) and be able to take the study medicine as a powder mixed with food after a meal.
- The child must already have an IV (intravenous) line in place as part of their regular care.
- The child must be in the hospital or an overnight clinic for at least 24 hours after receiving the study medicine.
- No unstable medical conditions, serious heart rhythm problems, severe kidney or liver disease, or weakened immune system.
- The child's body mass index (BMI) must be within the 5th to 95th percentile for their age.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how much of an antibiotic called gepotidacin passes into breast milk. Researchers will give healthy breastfeeding women a single dose and collect milk samples to understand if it's safe for nursing infants.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This trial tests a new combination of antibiotics (sulbactam-durlobactam) for children with a serious infection caused by Acinetobacter bacteria. The goal is to see if this treatment is safe and works well for kids.
This study follows pregnant people who took the antibiotic gepotidacin (or a standard treatment for a urinary tract infection) during pregnancy, to monitor their health and their baby's health. It helps us learn if the medicine is safe to use.
This study tests a new IV antibiotic combination (cefepime-enmetazobactam) for children with complicated urinary tract infections or kidney infections. The goal is to see how well it works and if it is safe.
This trial tests whether one dose of intravenous (IV) antibiotics is as effective as the usual multiple-dose course for children with complicated urinary tract infections (UTIs) who need IV treatment in the emergency department. It aims to reduce hospital stays and the need for repeated IV lines.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.